Intuity Medical (POGO) Files For Up to $75M IPO

Intuity Medical (NASDAQ: POGO) files for up to $75,000,000 IPO.

The company describes itself as: "We are a commercial-stage medical technology and digital health company focused on developing comprehensive solutions to improve the health and quality of life of people with diabetes. We developed our first commercial product, the POGO Automatic Blood Glucose Monitoring System, or POGO Automatic, to revolutionize the blood glucose testing process for individuals living with diabetes. POGO Automatic is a U.S. Food and Drug Administration, or FDA, cleared, automated, self-contained handheld monitor that enables patients to accurately measure blood glucose levels within seconds. POGO Automatic, combined with our Patterns app, offers full connectivity through our secure cloud-based digital health ecosystem, the Patterns app, which centralizes each patient’s blood glucose testing data in a digital form that can be shared with healthcare providers and others who play a central role in assisting with a patient’s diabetes treatment and testing regimen. We believe the convenience and simplicity of POGO Automatic will help remove the barriers to traditional glucose testing for people diagnosed with diabetes, and help them achieve their glucose level goals."

Goldman Sachs & Co. LLC. Jefferies, Piper Sandler and Raymond James will serve as underwriters.

You May Also Be Interested In

• Rubrik IPO: 5 key things to know
• CorMedix (CRMD) Announces CMS Grants TDAPA to DefenCath
• Mingteng International (MTEN) Opens At $4, IPO At $4 (earlier)